These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93. Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenström's macroglobulinemia. Chaudhry M; Steiner R; Claussen C; Patel K; Lee H; Weber D; Thomas S; Feng C; Amini B; Orlowski R; Feng L; Manasanch EE Leuk Lymphoma; 2019 Apr; 60(4):964-970. PubMed ID: 30227761 [TBL] [Abstract][Full Text] [Related]
94. Dutch Physician's Perspectives on Diagnosis and Treatment of Waldenström's Macroglobulinemia Before and After the Implementation of a National Guideline. Amaador K; Kersten MJ; Minnema MC; Vos JMI Hemasphere; 2022 Jul; 6(7):e746. PubMed ID: 35813102 [TBL] [Abstract][Full Text] [Related]
95. Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection. Kapoor P; Paludo J; Ansell SM Curr Treat Options Oncol; 2016 Mar; 17(3):16. PubMed ID: 26942591 [TBL] [Abstract][Full Text] [Related]
96. Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. Gertz MA Am J Hematol; 2019 Feb; 94(2):266-276. PubMed ID: 30328142 [TBL] [Abstract][Full Text] [Related]
97. Novel agents in Waldenstrom Macroglobulinemia. Sacco A; Leleu X; Rossi G; Ghobrial IM; Roccaro AM Open J Hematol; 2010 May; 1():. PubMed ID: 22844582 [TBL] [Abstract][Full Text] [Related]
98. Ibrutinib for the treatment of Waldenström macroglobulinemia. Chakraborty R; Kapoor P; Ansell SM; Gertz MA Expert Rev Hematol; 2015 Oct; 8(5):569-79. PubMed ID: 26138997 [TBL] [Abstract][Full Text] [Related]
99. Alkylating Agents in the Treatment of Waldenström Macroglobulinemia. Buske C Hematol Oncol Clin North Am; 2018 Oct; 32(5):821-827. PubMed ID: 30190020 [TBL] [Abstract][Full Text] [Related]
100. Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia? Sarosiek S; Treon SP; Branagan AR; Castillo JJ J Clin Oncol; 2023 Aug; 41(24):4059-4060. PubMed ID: 37348023 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]